KEATING LAURIE 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Aug 9, 2021
Insider Transaction Report
Form 4
KEATING LAURIE
SVP,GC & Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$88.95/sh+7,876$700,570→ 13,008 total - Sale
Common Stock
2021-08-05$188.95/sh−10,000$1,889,500→ 5,132 total - Exercise/Conversion
Performance Stock Option 2015 (right to buy)
2021-08-05−2,124→ 11,876 totalExercise: $88.95From: 2019-08-06Exp: 2025-12-18→ Common Stock (2,124 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-08-05−7,876→ 1,124 totalExercise: $88.95Exp: 2025-12-18→ Common Stock (7,876 underlying) - Exercise/Conversion
Common Stock
2021-08-05$88.95/sh+2,124$188,930→ 15,132 total
Holdings
- 434(indirect: by Managed Account)
Common Stock
Footnotes (3)
- [F1]All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
- [F2]Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- [F3]The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.